We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEXEA
4326
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
-644
Closed -$34K
PETX
4327
DELISTED
Aratana Therapeutics, Inc.
PETX
-8,524
Closed -$52K
BRSS
4328
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
-1,367
Closed -$46K
HF
4329
DELISTED
HFF Inc.
HF
-4,226
Closed -$167K
CZFC
4330
DELISTED
Citizens First Corporation
CZFC
-562
Closed -$13K
LABL
4331
DELISTED
Multi-Color Corp
LABL
-1,600
Closed -$131K
HIG.WS
4332
DELISTED
Hartford Financial Services Grp
HIG.WS
$0 ﹤0.01%
3
INSY
4333
DELISTED
Insys Therapeutics, Inc.
INSY
-3,578
Closed -$32K
KEYW
4334
DELISTED
The KEYW Holding Corporation
KEYW
$0 ﹤0.01%
38
-10,376
-100% -$65K
TVPT
4335
DELISTED
Travelport Worldwide Limited
TVPT
$0 ﹤0.01%
11
-14,265
-100% -$203K
EPE
4336
DELISTED
EP Energy Corporation
EPE
-9,871
Closed -$32K
WFT
4337
DELISTED
Weatherford International plc
WFT
-1,995
Closed -$9K
VISL
4338
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
0
HZNP
4339
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-16,463
Closed -$209K
BEL
4340
DELISTED
Belmond Ltd.
BEL
-6,273
Closed -$85K
CMTA
4341
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
-200
Closed -$3K
APF
4342
DELISTED
Morgan Stanley Asia Pacific Fund
APF
-334
Closed -$6K
TIS
4343
DELISTED
Orchids Paper Products, Inc.
TIS
-396
Closed -$6K
CLD
4344
DELISTED
Cloud Peak Energy Inc
CLD
-9,445
Closed -$35K
IPCI
4345
DELISTED
Intellipharmaceuticals International Inc.
IPCI
$0 ﹤0.01%
50
+30
+150% +$273
CIVI
4346
DELISTED
Civitas Solutions, Inc.
CIVI
-2,930
Closed -$55K
SGYP
4347
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
-1,632
Closed -$5K
GZT
4348
DELISTED
Gazit-globe Ltd
GZT
-62
Closed -$612
TLP
4349
DELISTED
Transmontaigne
TLP
-3,609
Closed -$154K
MB
4350
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
-17,588
Closed -$455K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.